SANUWAVE Health, Inc. (SNWV)
- Previous Close
0.0230 - Open
0.0212 - Bid --
- Ask --
- Day's Range
0.0187 - 0.0212 - 52 Week Range
0.0046 - 0.0298 - Volume
23,850 - Avg. Volume
334,409 - Market Cap (intraday)
21.351M - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
sanuwave.comRecent News: SNWV
Performance Overview: SNWV
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SNWV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SNWV
Valuation Measures
Market Cap
21.35M
Enterprise Value
50.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
--
Enterprise Value/Revenue
2.45
Enterprise Value/EBITDA
-5.46
Financial Highlights
Profitability and Income Statement
Profit Margin
-126.52%
Return on Assets (ttm)
-1.60%
Return on Equity (ttm)
--
Revenue (ttm)
20.4M
Net Income Avi to Common (ttm)
-25.81M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.8M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
9.3M
Research Analysis: SNWV
Company Insights: SNWV
SNWV does not have Company Insights